数字农科院2.0

Schistosoma japonicum sja-let-7 Inhibits the Growth of Hepatocellular Carcinoma Cells via Cross-Species Regulation of Col1α2

文献类型: 外文期刊

作者: Haoran Zhong;Bowen Dong;Danlin Zhu;Zhiqiang Fu;Jinming Liu;Guiquan Guan;Yamei Jin

作者机构:

关键词: Col1α2;hepatocellular carcinoma;liver fibrosis;schistosome;sja-let-7

期刊名称: Genes

ISSN: 2073-4425

年卷期: 2024 年 15 卷 9 期

页码:

收录情况: SCIE(2024版)

摘要: Liver fibrosis, a critical precursor to hepatocellular carcinoma (HCC), results from chronic liver injury and significantly contributes to HCC progression. Schistosomiasis, a neglected tropical disease, is known to cause liver fibrosis; however, this process can be modulated by schistosome-derived miRNAs. Previous studies from our laboratory have demonstrated that Schistosoma japonicum extracellular vesicles (EVs) deliver sja-let-7 to hepatic stellate cells, leading to the inhibition of Col1α2 expression and alleviation of liver fibrosis. Given the well-documented antifibrotic and antiproliferative properties of the let-7 miRNA family, this study aims to preliminarily investigate the effects of the sja-let-7/Col1α2 axis on BALB/c mice and HCC cell line SNU387, providing a basis for the potential application of parasite-derived molecules in HCC therapy. In the present study, schistosome-induced fibrosis datasets were analyzed to identify the role of Col1α2 in extracellular matrix organization. Pan-cancer analysis revealed that Col1α2 is upregulated in various cancers, including HCC, with significant associations with immune cell infiltration and clinical parameters, highlighting its diagnostic importance. Functional assays demonstrated that transfection with sja-let-7 mimics significantly reduced Col1α2 expression, inhibited HCC cell proliferation, migration, and colony formation. These findings suggest that sja-let-7, by targeting Col1α2, has the potential to serve as a therapeutic agent in HCC treatment. This study indicates the pivotal role of Col1α2 in liver fibrosis and HCC, and the promising therapeutic application of helminth-derived miRNAs.

分类号:

  • 相关文献

[1]日本血吸虫小RNA let-7对虫体生殖发育影响的研究. 冯金涛,韩愉,乔洪宾,张欣,李浩,陆珂,林矫矫,刘金明,金亚美. 2017

[2]Role of sja-let-7 in egg production and reproductive development in female Schistosoma japonicum. Haoran Zhong,Danlin Zhu,Bowen Dong,Hao Li,Zhiqiang Fu,Jinming Liu,Guiquan Guan,Yamei Jin. 2025

[3]Role of microRNAs in schistosomes and schistosomiasis. Zhu, Lihui,Liu, Jinming,Cheng, Guofeng. 2014

[4]MicroRNAs: Potentially important regulators for schistosome development and therapeutic targets against schistosomiasis. Cheng, Guofeng,Jin, Youxin,Jin, Youxin. 2012

[5]Epigenetics in Schistosomes: What We know and What We Need know. Liu, Weiwei. 2016

[6]Altered levels of circulating miRNAs are associated Schistosoma japonicum infection in mice. Zhu, Lihui,Dao, Jinwei,Du, Xiaoli,Li, Hao,Lu, Ke,Liu, Jinming,Cheng, Guofeng. 2015

[7]Single-sex schistosomiasis: a mini review. Zhong, Haoran,Jin, Yamei. 2023

[8]Characterisation and preliminary functional analysis of N-acetyltransferase 13 from Schistosoma japonicum. Yalan Tang,Kerou Zhou,Qingqing Guo,Cheng Chen,Jing Jia,Qinghong Guo,Ke Lu,Hao Li,Zhiqiang Fu,Jinming Liu,Jiaojiao Lin,Xingang Yu,Yang Hong. 2021

[9]Commentary: Molecular characterization of Smtdc-1 and Smddc-1 discloses roles as male-competence factors for the sexual maturation of Schistosoma mansoni females. Haoran Zhong,Yamei Jin. 2025

[10]Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics. Shang, Xiaofei,Yuan, Huixin,Dai, Lixia,Liu, Yang,He, Jian,Chen, Huan,Li, Hongyan,Li, Xiuhui. 2022

[11]Lingonberry Anthocyanins Inhibit Hepatic Stellate Cell Activation and Liver Fibrosis via TGFβ/Smad/ERK Signaling Pathway. Guokun Zhang,Yunyao Jiang,Xin Liu,Yongyan Deng,Bin Wei,Liyan Shi. 2021

[12]Multifunctional Roles of MicroRNAs in Schistosomiasis. Zhong, Haoran,Jin, Yamei. 2022

[13]Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy. Li, Hong,Liu, Tingli,Yang, Yongchun,Cho, William C.,Flynn, Robin J.,Harandi, Majid Fasihi,Song, Houhui,Luo, Xuenong,Zheng, Yadong. 2023

[14]A novel RELA K119 deacetylation mediated by SIRT7 is a pivotal activator to exacerbate liver inflammation and fibrosis in teleosts. Wu, Xiaoliang,Liang, Xiaofang,Li, Min,Liu, Jiacheng,Ge, Chunyu,Xie, Xiaoze,Wang, Jie,Zheng, Yinhua,Wang, Hao,Wu, Xiufeng,Gu, Xu,Xue, Min. 2025

[15]Commentary: Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs. Haoran Zhong,Yamei Jin. 2025

[16]RNA sequencing analysis reveals the impact of Schistosoma japonicum worm on host liver fibrosis. Haoran Zhong,Bowen Dong,Danlin Zhu,Zhiqiang Fu,Jinming Liu,Guiquan Guan,Yamei Jin. 2025

[17]Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics. Wang, Yingchao,Liu, Hongzhi,Liang, Dong,Huang, Yao,Zeng, Yongyi,Xing, Xiaohua,Xia, Jiangbao,Lin, Minjie,Liao, Naishun,Liu, Xiaolong,Liu, Jingfeng,Wang, Yingchao,Liu, Hongzhi,Liang, Dong,Huang, Yao,Zeng, Yongyi,Xing, Xiaohua,Xia, Jiangbao,Lin, Minjie,Liao, Naishun,Liu, Xiaolong,Liu, Jingfeng,Liu, Hongzhi,Liang, Dong,Huang, Yao,Zeng, Yongyi,Liu, Jingfeng,Han, Xiao.

[18]Reveal The Molecular Signatures Of H.epatocellular Carcinoma With Different S izes By Itraq Based Quantitative Proteomics. Liu, Xiaolong,Wang, Yingchao,Wang, Yingchao,Liu, Xiaolong,Liu, Jingfeng,Liu, Jingfeng,Liu, Jingfeng,Zeng, Yongyi,Zeng, Yongyi,Zeng, Yongyi,Xing, Xiaohua,Xia, Jiangbao,Xia, Jiangbao,Xing, Xiaohua,Liang, Dong,Liang, Dong,Liang, Dong,Huang, Yao,Han, Xiao,Huang, Yao,Huang, Yao,Liu, Hongzhi,Liu, Hongzhi,Liu, Hongzhi,Lin, Minjie,Liao, Naishun,Liao, Naishun,Lin, Minjie. 2017

[19]Potentiation of resveratrol-induced apoptosis by matrine in human hepatoma HepG2 cells. Ou, Xiuyuan,Zhang, Xumeng,He, Qiyang,Ou, Xiuyuan,Zhang, Xumeng,He, Qiyang,Ou, Xiuyuan,Chen, Yan,Chen, Yan,Cheng, Xinxin,Cheng, Xinxin.

[20]Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy. Wu, Yunzhou,An, Ying,Yan, Shijun,Yin, Jiechao,Li, Deshan,He, Jinjiao,Geng, Jingshu,Ye, Xianlong,Yu, Qingzhong,Zhang, Zhenyu.

作者其他论文 更多>>